Trans Reg NCP



	Trans Reg NCP PST General Idea Data base structure Browse RDC by country by sector of activity (NACE) all entries Browse Project Proposal by call by proposal NACE all entries Account Registration Login Contact us NCP list

See this RDC contact information See PPs submitted by this RDC

RDC Administrative Data
RDC Name	BioValley The Life Science Network
RDC short name	BioValley
Region of direct impact and rooting	FRANCE - Alsace GERMANY - Saarland SWITZERLAND - Nordwestschweiz
Internet homepage	www.biovalley.com/content.cfm?nav=1&content=2
Name of the RDC Coordinating Entity	Alsace BioValley Mr. Nicolas Carboni General Manager Parc d'Innovation
Postal address
Street Name	Bd Gonthier d'Andernach
Number	9
Town	Illkirch
Postal Code/Cedex	F- 67400
Country	France
Basic characteristics of RDC
RDC participants' structure	Number of local authorities representatives 3-5 Number of research entities 4-10 Number of companies 21-100
RDC human resources	Number of employees <500 Number of researchers <100
Sector of activity (NACE)	Manufacture of basic pharmaceutical products and pharmaceuti Scientific research and development Human health activities
RDC type of development	Bottom up top-down Sectored Restricted membership Regional impact
RDC stage of development	Cluster set-up phase
Management structure	Cluster of the form of legal entity
Cluster strategy	Strategy for development
RDC Activities
Areas of cooperation in the frame of cluster activities.	Joint research Joint product or technology development Diffusion of technology within cluster (technology transfer) Joint training activities for employees Development of common technical standards Common market research Cluster lobbying Common marketing and promotion Common supply/distribution Shared infrastructure (laboratories, equipment, etc)
Communication and information	Development of communication platform Regular stakeholders visits Regular events (workshops, expert round tables, specialist even Newsletter Cluster's database Homepage
Financing of the cluster's activities	Structure of cluster financing (own resources/outer resources) <20% Outer private financial resources received used for common projects/activities during the last 3 years <1mln Outer public financial resources received used for common projects/activities during the last 3 years <1mln Spendings on common R&D projects <1mln Spendings on investments in common cluster infrastructure during the last 3 years (common infrastructure) <10
Cluster internationalization	Access to international events Participation in international projects Set-up of network activities between different clusters Cooperation with foreign entities
Marketing and PR	Common commercials Common participation in fairs and trades Common visualisation (logo, colours, webpage) Common information policy
Trainings	Common conferences and seminars Common trainings and workshops Common publications Study tours to cluster partners
RDC Impact and results
Knowledge and innovation development	% of cluster SME innovating in-house in the last 3 years <10 % of cluster SME cooperating with R&D organizations (based on agreements) in the last 3 years <10 Number of start-ups in cluster in all cluster history <10 Number of cluster transnational cooperation agreements <2
Increase of the regional and branch competitiveness	Increase of employment within cluster for the last 3 years no increase <10% Increase in number of new entities joining the cluster (research organizations, companies) in the last 3 years <10% Transnational sales as a % of total cluster companies turnover for the last 3 years <20% Sales of new to market products as % of total cluster companies turnover <5% FDI in region in sector specific to cluster in the last 3 years <100mln
RDC Activities
Most important project in the last 3 years (started or completed) having impact on cluster development including results, source of funding and approx. budget.	2002-2007: Interreg III European Program for BioValley? with a global sum of ? 2,752,750: "BioValley: from network to tri-national biotech cluster". 2008-2011: Interreg IV Upper Rhine European Program for BioValley? with a global sum of ? 1,413,800 "BioValley: the life sciences and medical technologies cluster for the economic development of the Upper Rhine Metropolitan Region
Most important research results implemented within cluster by more than one enterprise (technical and organizational innovations, technology transfers, etc) Short description of the project and results
Most important research infrastructure available (with special attention on industrial applications and availability for transnational collaboration) (without office equipment) Short description of the laboratory	11 Life Sciences Parks ?12 Universities and academic institutes offering Life Sciences, Biotech, Chemistry or Nanosciences curricula ?Over 30 qualified technology platforms for scientific services: Screening, ADME, Spectroscopy, NMR, Phenotyping, Clinical research, etc. The technology platforms have been evaluated and their services can be offered.
Please specify infrastructure you need access to in particular research infrastructure (if any)

Other networks: